Hair becoming brittle, dull, or thin
The growth is attributed to its strong clinical performance, precise targeting, and long half-life properties
If you want to think about combination therapy seriously, watch for FDA approvals of CagriSema, MariTide (amylin/GLP-1), retatrutide, and oral orforglipron
Gastrointestinal side effects are typically mild to moderate and often improve during dose escalation
During this window, substances applied to the skin surface can penetrate directly to the dermis at concentrations that approach injectable delivery
Your provider will continuously monitor your condition and adjust the treatment plan as needed